NeoPharm Granted Extension to Regain Listing Compliance on NASDAQ

LAKE BLUFF, Ill.--(BUSINESS WIRE)--NeoPharm, Inc. (NASDAQ:NEOL), today announced that the Company has received notice from the NASDAQ Listing Qualifications Panel (the “Panel”) informing the Company that the Panel has extended the deadline for NeoPharm to regain compliance with NASDAQ’s minimum bid price requirement to March 27, 2009 from December 22, 2008.
MORE ON THIS TOPIC